Should Biotechnology Stock Kinnate Biopharma Inc (KNTE) Be in Your Portfolio Wednesday?

Wednesday, November 15, 2023 10:09 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Kinnate Biopharma Inc (KNTE) Be in Your Portfolio Wednesday?

A rating of 36 puts Kinnate Biopharma Inc (KNTE) near the middle of the Biotechnology industry according to InvestorsObserver. Kinnate Biopharma Inc's score of 36 means it scores higher than 36% of stocks in the industry. Kinnate Biopharma Inc also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 49 out of the 148 industries.

KNTE has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on KNTE!

See Full KNTE Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Kinnate Biopharma Inc Stock Today?

Kinnate Biopharma Inc (KNTE) stock is trading at $2.38 as of 10:09 AM on Wednesday, Nov 15, an increase of $0.80, or 51.27% from the previous closing price of $1.57. Volume today is high. So far 24,973,255 shares have traded compared to average volume of 111,366 shares. The stock has traded between $2.04 and $2.43 so far today. Click Here to get the full Stock Report for Kinnate Biopharma Inc stock.